Filter By

Recent Articles

Learn How the Adenovirus-Based Vaccine Offers Protection from COVID-19

ASGCT Staff | April 09, 2021

ASGCT has created new Patient Education resources to explain how the latest adenovirus-based vaccine works to offer protection from COVID-19.

Read Full Story

FDA Approves First Cell-Based Gene Therapy for Multiple Myeloma

Rayne Rouce, M.D. | April 02, 2021

Idecabtagene vicleucel (ide-cel) is the first FDA-approved cell-based gene therapy for adults with relapsed or refractory multiple myeloma, and the first CAR T-cell therapy in the B-cell maturation antigen (BCMA) class.

Read Full Story

Five Questions with Maritza McIntyre, Ph.D., for Women's History Month

Catherine Gillespie | March 29, 2021

Maritza McIntyre, Ph.D., talks about the impact her gender had on getting her start in the field, the female researchers who made up her support network along the way, and telling her mentees to speak up and claim their space.

Read Full Story

Vote in the 2021 ASGCT Elections

ASGCT Staff | March 24, 2021

ASGCT's members have the ability to direct the Society by voting for ASGCT's Board of Directors before April 20.

Read Full Story

Five Questions with Vivian Choi, Ph.D., for Women's History Month

Catherine Gillespie | March 22, 2021

Vivian Choi, Ph.D, talks about the critical role mentorship has played in her career, breaking out of her shell, and paying forward what she's learned.

Read Full Story

Five Questions with Catherine Bollard, M.D., for Women's History Month

Catherine Gillespie | March 15, 2021

Catherine Bollard, M.D., talks about how a friend's cancer diagnosis spurred her passion for cellular immunotherapy, her experiences with her own mentors, and her "boots on the ground" approach to mentorship.

Read Full Story

Remembering Physician-Scientist and Mentor Arthur Nienhuis

Cynthia E. Dunbar, M.D., and David Bodine, Ph.D. | March 10, 2021

Arthur Nienhuis was a past president of ASGCT.

Read Full Story

Mavis Agbandje-McKenna’s Lifelong Commitment to Teaching and Research

Barry J. Byrne, M.D., Ph.D., Angela L. McCall, Ph.D., Beverly L. Davidson, Ph.D., and R. Jude Samulski, Ph.D.  | March 10, 2021

Mavis Agbandje-McKenna was the recipient of ASGCT's 2020 Outstanding Achievement Award.

Read Full Story

Five Questions with Helen Heslop, M.D., for International Women’s Day

Catherine Gillespie | March 08, 2021

In our first interview during Women's History Month, we talked to ASGCT Past President Helen Heslop, M.D., about the importance of mentorship for women in science.

Read Full Story

New Diversity and Inclusion Awards Aim to Promote Equity in Gene and Cell Therapy Research

David Barrett, J.D., M.S. | February 26, 2021

The application period for three new funding opportunities will open in June.

Read Full Story

Associate Members: Register for #ASGCT21 for Free

ASGCT Staff | February 22, 2021

To show our appreciation, ASGCT is offering new membership benefits for 2021.

Read Full Story

Supporting Gene Therapy Research and Access for Minority Populations

Allistair Abraham, M.D., and Rayne Rouce, M.D. | February 19, 2021

During Black History Month, we wanted to pose the important question: What can we do to support the development of and increase access to cell and gene therapies for diseases that predominantly affect underrepresented minority communities?



Read Full Story

Microscopy of spinal cord sample from a mouse model of neurodegeneration. Credit: NICHD/NIH, J. Gluski & C. Le Pichon C.

Q&A with Lorenz Studer, M.D.

Cenk Sumen, Ph.D. | February 18, 2021

Lorenz Studer, M.D., is the director of the Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Center. His lab aims to exploit recent advances in stem cell biology to develop radically new therapies for degenerative disease and cancer. In this Q&A, Dr. Studer spoke with Cenk Sumen, Ph.D., about how he got started in the field, his research and challenges, and his advice for young scientists.

Read Full Story

Closing the Mentorship Gap for Minorities

Rayne Rouce, M.D. | February 10, 2021

We must be intentional in our efforts to mentor, recruit, and retain underrepresented minorities within our laboratories, our clinical divisions, and our outreach programs.

Read Full Story

World Cancer Day 2021: Gene and Cell Therapies for Colorectal Cancers

Eoghan J. Mulholland, Ph.D. | February 04, 2021

On World Cancer Day, Dr. Eoghan Mulholland discusses colorectal cancer and how gene and cell therapy offers potential in its treatment and prevention.

Read Full Story

Diversity and Inclusion Committee Plans to Expand Society’s Reach and Resources

Rayne Rouce, M.D. | February 01, 2021

To recognize Black History Month, this weekly series will introduce ASGCT's new Diversity and Inclusion Committee and highlight gene therapy research initiatives aimed at improving outcomes for diseases that disproportionately affect the Black community.

Read Full Story

ASGCT 24th Annual Meeting

May 11-14, 2021